Asia Pacific Pharmaceutical Glass Packaging Industry Overview
The Asia-Pacific glass packaging market is fragmented, with increasing investments and the launch of injectables and other medicines opening opportunities in the sector. Rivalry among competitors such as Becton, Dickinson and Company, SGD SA, Gerresheimer AG, Schott AG, and AGI glaspac -AGI Greenpac Limited is high. Horizontal and vertical integration of companies in the pharmaceutical industry is anticipated to fuel the demand for glass packaging.
- June 2024 - BD (Becton, Dickinson, and Company), a global medical technology company, and Edwards Lifesciences announced an agreement under which BD will acquire Edwards' Critical Care product group, one of the global leaders in advanced monitoring solutions, forĀ USD 4.2 billion. This will unlock new value-creation opportunities and enhance BD's innovative connected care solutions portfolio.
- October 2023 - SCHOTT AG is constantly enhancing its materials while making them more sustainable. With its borosilicate glass being the gold standard for storing lifesaving medications for over a century, the company is taking the following steps by introducing improved glass tubing to the global pharmaceutical market. FIOLAX Pro is a new type I borosilicate glass developed to address three significant trends in increasingly complex pharmaceuticals: sustainable products, circular economy, and digitalization.
Asia Pacific Pharmaceutical Glass Packaging Market Leaders
-
AGI glaspac - AGI Greenpac Limited
-
Schott AG
-
Becton, Dickinson, And Company
-
Gerresheimer AG
-
SGD S.A.
- *Disclaimer: Major Players sorted in no particular order
